CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.500
+0.390 (9.49%)
At close: Mar 9, 2026, 4:00 PM EDT
4.990
+0.490 (10.89%)
After-hours: Mar 9, 2026, 4:03 PM EDT
CervoMed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 6.16 | 9.74 | 7.14 | - | - |
| Revenue Growth (YoY) | -38.81% | 36.29% | - | - | - |
| Cost of Revenue | 23.07 | 18.8 | 8.44 | 1.34 | - |
| Gross Profit | -16.91 | -9.06 | -1.29 | -1.34 | - |
| Selling, General & Admin | 10.29 | 9.17 | 6.52 | 2.14 | 2.62 |
| Research & Development | - | - | - | - | 2.42 |
| Operating Expenses | 10.29 | 9.17 | 6.52 | 2.14 | 5.04 |
| Operating Income | -27.2 | -18.23 | -7.81 | -3.48 | -5.04 |
| Interest Expense | - | - | - | -0 | -0 |
| Interest & Investment Income | 1.63 | 1.94 | 0.22 | 0.06 | 0.02 |
| Other Non Operating Income (Expenses) | -0.01 | -0 | 5.42 | -2.39 | 0.74 |
| EBT Excluding Unusual Items | -25.58 | -16.29 | -2.17 | -5.8 | -4.28 |
| Other Unusual Items | - | - | - | - | 0.15 |
| Pretax Income | -25.58 | -16.29 | -2.17 | -5.8 | -4.14 |
| Net Income | -25.58 | -16.29 | -2.17 | -5.8 | -4.14 |
| Net Income to Common | -25.58 | -16.29 | -2.17 | -5.8 | -4.14 |
| Shares Outstanding (Basic) | 9 | 8 | 3 | 1 | 5 |
| Shares Outstanding (Diluted) | 9 | 8 | 3 | 1 | 5 |
| Shares Change (YoY) | 19.30% | 203.34% | 413.65% | -88.49% | - |
| EPS (Basic) | -2.87 | -2.02 | -0.82 | -11.20 | -0.92 |
| EPS (Diluted) | -2.87 | -2.02 | -0.82 | -11.20 | -0.92 |
| Gross Margin | -274.58% | -93.04% | -18.11% | - | - |
| Operating Margin | -441.64% | -187.18% | -109.35% | - | - |
| Profit Margin | -415.36% | -167.29% | -30.40% | - | - |
| EBIT | -27.2 | -18.23 | -7.81 | -3.48 | -5.04 |
| EBIT Margin | - | -187.18% | -109.35% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.